Edition:
United Kingdom

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

534.30INR
23 Feb 2018
Change (% chg)

Rs10.75 (+2.05%)
Prev Close
Rs523.55
Open
Rs525.00
Day's High
Rs536.65
Day's Low
Rs524.95
Volume
929,934
Avg. Vol
1,033,597
52-wk High
Rs950.00
52-wk Low
Rs517.05

Select another date:

Wed, Feb 21 2018

BRIEF-Glenmark Pharma Enters Exclusive Collaboration Agreement with SCD Pharmaceuticals

* GLENMARK PHARMACEUTICALS - ‍ENTERED INTO EXCLUSIVE DEAL WITH SAM CHUN DANG PHARM

BRIEF-India's Glenmark Pharmaceuticals Dec-Qtr Consol Profit Falls 78 Pct

* DEC QUARTER CONSOL PROFIT 1.05 BILLION RUPEES VERSUS PROFIT OF 4.77 BILLION RUPEES LAST YEAR

BRIEF-Glenmark Pharma Gets Permission From CDSCO For Phase IIb Dose Range Finding Study For GRC 27864

* GETS PERMISSION BY CENTRAL DRUGS STANDARD CONTROL ORGANIZATION FOR PHASE IIB DOSE RANGE FINDING STUDY FOR GRC 27864 Source text - http://bit.ly/2mEqR6R Further company coverage:

BRIEF-Glenmark Pharmaceuticals Launches Biosimilar Of Adalimumab In India

* LAUNCHES BIOSIMILAR OF ADALIMUMAB IN INDIA Source text for Eikon: Further company coverage:

BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval For Norethindrone Acetate, Ethinyl Estradiol Tablets

* GETS ANDA APPROVAL FOR NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS USP AND FERROUS FUMARATE TABLETS Source text - http://bit.ly/2BGPRjs Further company coverage:

BRIEF-Glenmark Pharmaceuticals Meets Primary Clinical Endpoint In Phase 3 Study Of Ryaltris

* SAYS MET ITS PRIMARY CLINICAL ENDPOINT IN A PHASE 3 STUDY EVALUATING SAFETY OF RYALTRIS

BRIEF-Glenmark Pharma Says Closed DCP For Generic Seretide Accuhaler In Nordic Region​

* ANNOUNCES CLOSURE OF DECENTRALISED REGISTRATION PROCEDURE (DCP) FOR GENERIC SERETIDE ACCUHALER IN NORDIC REGION​ Source text - http://bit.ly/2ByD8zw Further company coverage:

BRIEF-Glenmark Pharma Says U.S. FDA issues 7 Form 483 observations for co's ‍Baddi Unit

* GLENMARK PHARMACEUTICALS SAYS ‍BADDI UNIT UNDERWENT AN U.S. FDA AUDIT FROM NOVEMBER 6, 2017 TO NOVEMBER 11, 2017

BRIEF-Glenmark Pharmaceuticals gets ANDA approval for HAILEY Fe 1/20 tablets ​

Nov 22 Glenmark Pharmaceuticals Ltd * Gets ANDA approval for HAILEY Fe 1/20 tablets ​ Source text - http://bit.ly/2hRulnp Further company coverage:

BRIEF-Glenmark Pharmaceuticals gets ANDA approval for Haileytm 24 FE 1 mg/20 mcg​

* Gets ANDA approval for Haileytm 24 fe 1 mg/20 mcg​ Source text for Eikon: Further company coverage:

Select another date: